JPS56122309A - Calcitonin pharmaceutical for rectal administration - Google Patents
Calcitonin pharmaceutical for rectal administrationInfo
- Publication number
- JPS56122309A JPS56122309A JP2519780A JP2519780A JPS56122309A JP S56122309 A JPS56122309 A JP S56122309A JP 2519780 A JP2519780 A JP 2519780A JP 2519780 A JP2519780 A JP 2519780A JP S56122309 A JPS56122309 A JP S56122309A
- Authority
- JP
- Japan
- Prior art keywords
- calcitonin
- pharmaceutical
- surfactant
- rectal administration
- hypercalcemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PURPOSE: To obtain the titled pharmaceutical, useful for hypercalcemia, particularly senile osteporosis, easily administrable, and prepared by dispersing calcitonin and surfactant in a suppository base uniformly.
CONSTITUTION: Calcitonin and a surfactant, e.g. sodlim glycolate, are dispersed in a suppository base, e.g. cacao butter, in a meat mill, etc. uniformly., and if necessary molded to give a calcitonin pharmaceutical for rectal administration. The surfactant is used in an amount of preferably 0.01W5mg based on 1MRC unit calcitonin. The calcitonin acts on the bone, intestinal tract, and kidney to reduce the calcium ions and inorganic phosphrous in blood, and is useful for hypercalcemia. However, the calcitonin has been administered only by injection. The pharmaceutical is a suppository easily administrable and effectively absorbed by the rectum.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2519780A JPS56122309A (en) | 1980-03-03 | 1980-03-03 | Calcitonin pharmaceutical for rectal administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2519780A JPS56122309A (en) | 1980-03-03 | 1980-03-03 | Calcitonin pharmaceutical for rectal administration |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56122309A true JPS56122309A (en) | 1981-09-25 |
JPS6236498B2 JPS6236498B2 (en) | 1987-08-07 |
Family
ID=12159222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2519780A Granted JPS56122309A (en) | 1980-03-03 | 1980-03-03 | Calcitonin pharmaceutical for rectal administration |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56122309A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5989619A (en) * | 1982-10-05 | 1984-05-23 | サンド・アクチエンゲゼルシヤフト | Calcitonin composition and use |
JPS59130820A (en) * | 1982-12-29 | 1984-07-27 | ア−マ−・フア−マシユ−テイカル・カンパニ− | Promotion of calcitonin absorption to nose inside with surfactant-containing composition |
JPS60161924A (en) * | 1984-02-01 | 1985-08-23 | Fujisawa Pharmaceut Co Ltd | Composition for lung absorption |
JPH02262526A (en) * | 1982-10-05 | 1990-10-25 | Sandoz Ag | Calcitonine composition and use thereof |
US5238917A (en) * | 1989-09-11 | 1993-08-24 | Teikoku Seiyaku Kabushiki Kaisha | High-absorbable transvaginal preparation containing biologically active polypeptide |
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
US5393738A (en) * | 1986-05-27 | 1995-02-28 | Sandoz, Ltd. | Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration |
WO1995033474A1 (en) * | 1994-06-03 | 1995-12-14 | Tsumura & Co. | Medicinal composition |
US5824646A (en) * | 1988-03-11 | 1998-10-20 | Teikoku Seiyaku Co., Ltd. | Intravaginal delivery of biologically active polypeptides |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0235595U (en) * | 1988-08-25 | 1990-03-07 |
-
1980
- 1980-03-03 JP JP2519780A patent/JPS56122309A/en active Granted
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5989619A (en) * | 1982-10-05 | 1984-05-23 | サンド・アクチエンゲゼルシヤフト | Calcitonin composition and use |
JPH02262526A (en) * | 1982-10-05 | 1990-10-25 | Sandoz Ag | Calcitonine composition and use thereof |
JPH0354647B2 (en) * | 1982-10-05 | 1991-08-20 | ||
JPS59130820A (en) * | 1982-12-29 | 1984-07-27 | ア−マ−・フア−マシユ−テイカル・カンパニ− | Promotion of calcitonin absorption to nose inside with surfactant-containing composition |
JPS60161924A (en) * | 1984-02-01 | 1985-08-23 | Fujisawa Pharmaceut Co Ltd | Composition for lung absorption |
US5393738A (en) * | 1986-05-27 | 1995-02-28 | Sandoz, Ltd. | Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration |
US5824646A (en) * | 1988-03-11 | 1998-10-20 | Teikoku Seiyaku Co., Ltd. | Intravaginal delivery of biologically active polypeptides |
US5840685A (en) * | 1988-03-11 | 1998-11-24 | Teikoku Seiyaku Co., Ltd. | Intravaginal delivery of biologically active polypeptides |
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
US5238917A (en) * | 1989-09-11 | 1993-08-24 | Teikoku Seiyaku Kabushiki Kaisha | High-absorbable transvaginal preparation containing biologically active polypeptide |
WO1995033474A1 (en) * | 1994-06-03 | 1995-12-14 | Tsumura & Co. | Medicinal composition |
Also Published As
Publication number | Publication date |
---|---|
JPS6236498B2 (en) | 1987-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS56122309A (en) | Calcitonin pharmaceutical for rectal administration | |
CA2144077A1 (en) | Hydrogel-type sustained-release preparation | |
JPS56140924A (en) | Calcitonin pharmaceutical preparation | |
JPS5228922A (en) | Medicine mixture for animals | |
FR2652501B1 (en) | THERAPEUTIC ELEMENTS FOR THE ORAL ADMINISTRATION OF A DRUG TO ANIMALS AND METHOD OF MANUFACTURE. | |
UA27954C2 (en) | Biologically active substance of a pharmaceutical composition for treatment of hyperglycemias and pharmaceutical composition having antihyperglicemical activity | |
JPS56118013A (en) | Calcitonin pharmaceutical and its preparation | |
JPS5677581A (en) | Diaphragm pump | |
JPS526660A (en) | Production of lactulose-including powders for livestock feed | |
JPS5774048A (en) | Solid feed for nursing pig | |
JPS5581282A (en) | Transfer device for induction unit of concrete pump | |
Slabý | Morphogenesis of the nasal capsule, the epithelial nasal tube and the organ of Jacobson in Sauropsida. VII. Morphogenesis and phylogenetic morphology of the nasal apparatus in Calotes jubatus O. B | |
JPS5328076A (en) | Separating apparatus for waste by dissolution | |
JPS57125659A (en) | Preparation of feed | |
JPS56103114A (en) | Drug for osteoporosis comprising 24r- hydroxycholecalciferol | |
JPS53119403A (en) | Motor-driven compressor | |
JPS55102517A (en) | Preparation of sulfamethoxazole-trimethoprim complex for administration via body cavity | |
JPS5549309A (en) | Suppository for remedy or prevention of diabetes | |
JPS5216376A (en) | Preventer of vagina from being left out | |
JPS5738724A (en) | Blood sugar level lowering agent | |
JPS5366692A (en) | Sludge processor | |
JPS5423131A (en) | Pharmaceutical composition containing acetylsalicylic acid and ethenzamide | |
JPS5269248A (en) | Data delivery and receipt control of data processor | |
FR2645746B1 (en) | ALKALINIZING SOLUTE FOR THE TREATMENT OF POST-NATAL AND DIARRHEIC METABOLIC ACIDOSIS OF CALVES | |
JPS5635948A (en) | Preparing method of solid food containing flesh extract from ume as main constituent |